Type of cell death induced by α-trifluoromethyl acyloins in oral squamous cell carcinoma

Anticancer Research

Volumn 29, Issue 1, 2009, Pages 175-181

  Ideo, Atsushi ^a   Hashimoto, Ken ^a   Shimada, Jun ^a   Kawase, Masami ^b   Sakagami, Hiroshi ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b MATSUYAMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Autophagy; Cytotoxic activity; Trifluoromethyl acyloins

Indexed keywords

ALPHA TRIFLUOROMETHYLACYLOIN DERIVATIVE; CASPASE 3; CASPASE 8; CASPASE 9; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; KETONE DERIVATIVE; LIPOCORTIN 5; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN LIGHT CHAIN 3; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CASPASES; CELL DEATH; CELL LINE, TUMOR; ENZYME ACTIVATION; FATTY ALCOHOLS; HUMANS; HYDROCARBONS, FLUORINATED; MOUTH NEOPLASMS;

EID: 61449224779     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Begue J-P and Bonnet-Delpon D: Preparation of trifluoromethyl ketones and related fluorinated ketones. Tetrahedron 47: 3207-3258, 1991.
2. Kawase M: Synthetic and medicinal chemistry of trifluoromethyl ketones. J Synth Org Chem Jpn 59: 755-765, 2001.
3. Kawase M, Harada H, Saito S, Cui J and Tani S: In vitro susceptibility of Helicobacter pylori to trifluoromethyl ketones. Bioorg Med Chem Lett 9: 193-194, 1999.
4. Kawase M, Motohashi N, Sakagami H, Kanamoto T, Nakashima H, Ferenczy K, Wolfard K, Miskolci C and Molnar J: Antimicrobial activity of trifluoromethyl ketones and their synergism with promethazine. Int J Antimicr Agents 18: 161-165, 2001.
5. Shao Y-M, Yang W-B, Kuo T-H, Tsai K-C, Lin C-H, Yang A-S, Liang P-H and Wong C-H: Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease. Bioorg Med Chem 16: 4652-4660, 2008.
6. Frey RR, Wada CK, Garland RB, Curtin ML, Michaelides MR, Li J, Pease LJ, Glaser KB, Marcotte PA, Bouska JJ, Murphy SS and Davidson SK: Trifluoromethyl ketones as inhibitors of histone deacetylase. Bioorg Med Chem Lett 12: 3443-3447, 2002.
7. Ideo A, Sasaki M, Nakamura C, Mori K, Shimada J, Kanda Y, Kunii S, Kawase M and Sakagami H: Cytotoxic activity of selected trifhioromethyl ketones against oral tumor cells. Anticancer Res 26: 4335-4341, 2006.
8. Kawase M, Sakagami H, Kusama K, Motohashi N and Saito S: α-Trifluoromethylated acyloins induce apoptosis in human oral tumor cell lines. Bioorg Med Chem Lett 9: 3113-3118, 1999.
9. Kawase M, Sunaga K, Tani S, Niwa M and Uematsu T: Trifluoromethyl ketone-based inhibitors of apoptosis in cerebellar granule neurons. Biol Pharm Bull 24: 1335-1337, 2001.
10. +-induced apoptosis in cerebellar granule neurons. In Vivo 16: 97-102, 2002.
11. Hatsukari I, Hitosugi N, Ohno R, Hashimoto K, Nakamura S, Satoh K, Nagasaka H, Matsumoto I and Sakagami H: Induction of apoptosis by morphine at clinical concentration against human tumor cell lines in vitro. Anticancer Res 27: 857-864, 2007.
12. Nakayachi T, Yasumoto E, Nakano K, Morshed SRM, Hashimoto K, Kikuchi H, Nishikawa H, Kawase M and Sakagami H: Strucuture-activity relationships of α,β-unsaturated ketones as assessed by their cytotoxicity against oral tumor cells. Anticancer Res 24: 732-742, 2004.
13. Yasumoto E, Nakano K, Nakayachi T, Morshed SRM, Hashimoto K, Kikuchi H, Nishikawa H, Kawase M and Sakagami H: Cytotoxic activity of deferiprone, maltol and related hydroxyketones against human tumor cell lines. Anticancer Res 24: 755-762, 2004.
14. Sekine T, Takahashi J, Nishishiro M, Arai A, Wakabayashi H, Kurihara T, Kobayashi M, Hashimoto K, Kikuchi H, Katayama T, Kanda Y, Kunii S, Motohashi N and Sakagami H: Tumor specificity and type of cell death induced by trihaloacetylazulenes in human tumor cell lines. Anticancer Res 27: 133-144, 2007.
15. Broker LE, Kruyt FAE and Giaccone G: Cell death independent of caspase: A review. Clin Cancer Res 11: 3155-3162, 2005.
16. Shimizu S and Tsuijimoto Y: Molecular mechanisms of autophagic cell death. SAIBO-KOGAKU 24: 581-586, 2005 (in Japanese).
17. Byfield MP, Murray JT and Backer JM: hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase. J Biol Chem 280: 33076-33082, 2005.
18. Nobukuni T, Joaquin M, Roccio M, Dann SG, Kim SY, Gulati P, Byfield MP, Backer JM, Natt F, Bos JL, Zwartkuis FJT and Thomas G: Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 30-H-kinase. Proc Natl Acad Sci USA 102: 14238-14243, 2005.
19. Jager S, Bucci C, Tanida I, Ueno T, Kominami E, Staffing P and Eskelinen EL: Role for Rab7 in maturation of late autophagic vacuoles. J Cell Sci 117: 4837-4848, 2004.
20. Kirisako T, Baba M, Ishihara N, Miyazawa K, Ohsumi M, Yoshimoto T, Noda T and Ohsumi Y: Formation process of autophagosome is traced with Apg8/Aut7p in yeast. J Cell Biol 147: 435-446, 1999.
21. Kondo Y, Kanzawa T, Sawaya R and Kondo S: Role of autophagy in cancer development and response to therapy. Nature Rev Cancer 5: 726-734, 2005.
22. Mills KR, Reginato M, Debnath J, Queenan B and Brugge JS: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro. Proc Natl Acad Sci USA 101: 3438-3443, 2001.
23. Lockshin RA and Zakeri Z: Apoptosis autophagy and more. Int J Biochem Cell Biol 36: 2405-2419, 2004.
24. Bursch W: Multiple cell death programs Charon's lifts to Hades. FEMS Yeast Res 5: 101-110, 2004.
25. Sakagami H, Kawase M, Wakabayashi H and Kurihara T: Factors that affect the type of cell death induced by chemicals. Autophagy 3: 493-495, 2007.